[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tarsus Pharmaceuticals Inc (TARS)

Tarsus Pharmaceuticals Inc (TARS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Tarsus Pharmaceuticals Inc 17700 LAGUNA CANYON ROAD FLOOR 4 IRVINE CA 92618 USA

www.tarsusrx.com Employees: 370 P: 949-418-1801

Sector:

Medical

Description:

Tarsus Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of therapeutic candidates to address ophthalmic conditions. The company's product candidate consist TP-03 which is in clinical stage. Tarsus Pharmaceuticals Inc. is based in IRVINE, Calif.

Key Statistics

Overview:

Market Capitalization, $K 3,098,798
Enterprise Value, $K 2,987,038
Shares Outstanding, K 43,883
Float, K 39,653
% Float 90.36%
Short Interest, K 6,017
Short Float 13.71%
Days to Cover 6.58
Short Volume Ratio 0.71
% of Insider Shareholders 9.64%
% of Institutional Shareholders 90.01%

Financials:

Annual Sales, $ 451,360 K
Annual Net Income, $ -66,420 K
Last Quarter Sales, $ 173,910 K
Last Quarter Net Income, $ -18,550 K
EBIT, $ -48,540 K
EBITDA, $ -51,610 K

Growth:

1-Year Return 28.71%
3-Year Return 306.30%
5-Year Return 177.03%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 63.19%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.43 on 08/06/26
Next Earnings Date 11/03/26
Earnings Per Share ttm -1.09
EPS Growth vs. Prev Qtr -168.75%
EPS Growth vs. Prev Year 10.42%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

TARS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -13.53%
Return-on-Assets % -8.12%
Profit Margin % -14.72%
Debt/Equity 0.21
Price/Sales 6.73
Price/Cash Flow N/A
Price/Book 8.72
Book Value/Share 7.90
Interest Coverage -6.20
60-Month Beta 0.53
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.